Vincerx Pharma
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Vincerx Pharma generated cash of -$40,453,000, which is more than the previous year. Cash used in financing activities reached the amount of $114,000 last year. Net change in cash is therefore $1,121,000.

Cash Flow

Vincerx Pharma, Inc. (NASDAQ:VINCW): Cash Flow
2019 -34.99K -65.63M 66.46M
2020 -2.27M -65.63M 64.07M
2021 -33.40M -5.25M 88.45M
2022 -59.60M -40.57M 280K
2023 -40.45M 41.5M 114K

VINCW Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
11.73M111.56M61.79M0-825.03K
Operating activities
Net income
-40.15M-65.36M-39.30M-10.72M-54K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
915K939K340K00
Stock-based compensation expense
3.56M10.05M23.31M4.38M1.2K
Deferred income tax benefit 3.56M10.05M23.31M4.38M1.2K
Changes in operating assets and liabilities:
Accounts receivable, net
328K200K000
Inventories
0-200K000
Accounts payable
-1.56M1.04M1.52M456K35K
Cash generated by operating activities
-40.45M-59.60M-33.40M-2.27M-34.99K
Investing activities
Purchases Of Investments
-11.82M-42.97M000
Investments In Property Plant And Equipment
00-5.25M00
Acquisitions Net
00000
Cash generated by investing activities
41.5M-40.57M-5.25M-65.63M-65.63M
Financing activities
Common Stock Issued
114K280K41.02M00
Payments for dividends
00000
Repurchases of common stock
00000
Repayments of term debt
000-300K0
Cash used in financing activities
114K280K88.45M64.07M66.46M
Net Change In Cash
1.12M-99.83M49.77M61.79M790.03K
Cash at end of period
12.85M11.73M111.56M61.79M-34.99K
Data sourceData sourceData sourceData source